Broadfin Capital as of Dec. 31, 2012
Portfolio Holdings for Broadfin Capital
Broadfin Capital holds 44 positions in its portfolio as reported in the December 2012 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Teva Pharmaceutical Industries (TEVA) | 10.6 | $43M | 1.2M | 37.34 | |
| Alkermes (ALKS) | 7.6 | $31M | 1.7M | 18.52 | |
| Natus Medical | 7.4 | $30M | 2.7M | 11.16 | |
| AngioDynamics (ANGO) | 5.7 | $23M | 2.1M | 10.99 | |
| Santarus | 5.5 | $22M | 2.0M | 10.98 | |
| Hi-Tech Pharmacal | 4.1 | $17M | 476k | 34.98 | |
| Novadaq Technologies | 3.8 | $15M | 1.7M | 8.83 | |
| Merit Medical Systems (MMSI) | 3.6 | $14M | 1.0M | 13.90 | |
| Alere | 3.4 | $14M | 736k | 18.50 | |
| Lannett Company | 3.1 | $13M | 2.6M | 4.96 | |
| Impax Laboratories | 2.8 | $11M | 551k | 20.49 | |
| Rigel Pharmaceuticals | 2.7 | $11M | 1.7M | 6.50 | |
| Progenics Pharmaceuticals | 2.7 | $11M | 3.7M | 2.98 | |
| DepoMed | 2.7 | $11M | 1.7M | 6.19 | |
| St. Jude Medical | 2.4 | $9.6M | 266k | 36.14 | |
| Solta Medical | 2.3 | $9.3M | 3.5M | 2.67 | |
| Emergent BioSolutions (EBS) | 2.3 | $9.2M | 572k | 16.04 | |
| Derma Sciences | 2.1 | $8.6M | 775k | 11.11 | |
| BioDelivery Sciences International | 2.0 | $8.0M | 1.9M | 4.31 | |
| Flamel Technologies | 1.9 | $7.5M | 2.5M | 3.03 | |
| Anacor Pharmaceuticals In | 1.8 | $7.3M | 1.4M | 5.20 | |
| MAKO Surgical | 1.6 | $6.4M | 500k | 12.85 | |
| Qlt | 1.5 | $6.2M | 785k | 7.86 | |
| Cempra | 1.5 | $5.9M | 923k | 6.40 | |
| Trius Therapeutics | 1.4 | $5.8M | 1.2M | 4.78 | |
| Abiomed | 1.3 | $5.4M | 400k | 13.44 | |
| Masimo Corporation (MASI) | 1.3 | $5.3M | 251k | 21.01 | |
| Auxilium Pharmaceuticals | 1.1 | $4.6M | 250k | 18.54 | |
| AtriCure (ATRC) | 1.1 | $4.6M | 660k | 6.90 | |
| DURECT Corporation | 1.1 | $4.5M | 4.9M | 0.92 | |
| ArthroCare Corporation | 1.1 | $4.4M | 127k | 34.59 | |
| Intellipharmaceuticsintl Inc C | 1.1 | $4.3M | 1.7M | 2.50 | |
| NuVasive | 1.1 | $4.2M | 275k | 15.46 | |
| NxStage Medical | 0.9 | $3.8M | 335k | 11.25 | |
| Nektar Therapeutics | 0.9 | $3.7M | 500k | 7.41 | |
| Rockwell Medical Technologies | 0.6 | $2.5M | 313k | 8.05 | |
| Insmed (INSM) | 0.4 | $1.8M | 267k | 6.69 | |
| Conceptus | 0.4 | $1.6M | 77k | 21.01 | |
| Oncothyreon | 0.4 | $1.4M | 750k | 1.92 | |
| Cardionet | 0.2 | $738k | 324k | 2.28 | |
| CAS Medical Systems | 0.1 | $476k | 222k | 2.15 | |
| Zeltiq Aesthetics | 0.1 | $470k | 102k | 4.63 | |
| Misonix | 0.1 | $343k | 43k | 8.05 | |
| Sucampo Pharmaceuticals | 0.1 | $284k | 58k | 4.90 |
